SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-15-004482
Filing Date
2015-06-02
Accepted
2015-06-02 16:15:54
Documents
1
Period of Report
2015-05-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-31621.html 3  
1 PRIMARY DOCUMENT marketforms-31621.xml 3 5435
  Complete submission text file 0001214659-15-004482.txt   6806
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5000 SHORELINE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Dickinson Klara (Reporting) CIK: 0001339895 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34637 | Film No.: 15907060